Double Blind Bio

Double Blind Bio builds AI agents that sit inside clinical-trial site and sponsor workflows, automating site selection, feasibility, study startup, and execution so research teams spend less time on repetitive admin. The company starts with research sites—embedding agents in the systems teams already use rather than adding another dashboard—then extends that network to sponsors. Founded by operators from Google, Verily, Flatiron Health, and Stanford, it is backed by Define Ventures, SignalFire, and Peterson Ventures.